Katie Heller
January 5, 2023
Watch a few of the ECOG-ACRIN cancer research advocates explain why cancer research is about more than just science
January 5, 2023
This study is for patients who have aggressive, high-grade tumors that put them at higher risk of recurrence after treatment
January 5, 2023
This trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)
January 5, 2023
This trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether